Faculty Awards - Faculty of Health Sciences - McMaster University

More documents

Recommendations

Info

158 PUBLICATIONS Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356:2653-2654. Whitlock RP, Crowther MA, Warkentin TE, Blackall MH, Farrokhyar F, Teoh K. Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K. Ann Thorac Surg 2007; 84:103-109. Warkentin TE. Heparin-induced thrombocytopenia. Hematol/Oncol Clin N Am 2007 Aug; 21:589-607. Selleng K, Lubenow LE, Greinacher A, Warkentin TE. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome). EurJ Haematol 2007; 79: 263-268. Warkentin TE, Sheppard JI, Raschke R, Greinacher A. Performance characteristics of a rapid assay for anti- PF4/heparin antibodies, the Particle ImmunoFiltration Assay. J Thromb Haemost 2007; 5:2308-2310. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 2007; 82:1037-1043. Anderson JAM, Simpson PJ, Leber B, Warkentin TE. Acute pancreatitis preceding thrombotic thrombocytopenic purpura. Haematologica 2007; 92:e94-e95. Refaai MA, Warkentin TE, Axelson M, Matevosyan K, Sarode R. Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin “flushes”. Thromb Haemost 2007; 98:1139-1140. Price EA, Hayward CPM, Moffat KA, Moore JC, Warkentin TE, Zehnder JL. Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America: a survey of North American Specialized Coagulation Laboratories. Thromb Haemost 2007; 98:1357-1361. Book Chapters Warkentin TE. The diagnosis and management of heparin-induced thrombocytopenia. In: Bergan JJ, ed. The Vein Book. Amsterdam: Elsevier Inc., 2007; 395- 403. Arnold DM, Warkentin TE. Thrombocytopenia and thrombocytosis (Chap. 55). In: Wilson WC, Grande CM, Hoyt DB, eds. Trauma: Critical Care (vol. 2). New York: Informa Healthcare USA, 2007; 983-1005. Warkentin TE. Leukocytosis and leukopenia (Chap. 57). In: Wilson WC, Grande CM, Hoyt DB, eds. Trauma: Critical Care (vol. 2). New York: Informa Healthcare USA, 2007; 1027-1037. Warkentin TE. History of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin- Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc.; 2007: 1-19. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc.; 2007: 21-66. Lee DH, Warkentin TE. Frequency of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc.; 2007: 67-116. Warkentin TE, Greinacher A. Laboratory testing for heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc.; 2007: 227-260. Warkentin TE. Pseudo-heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A, eds. Heparin- Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc.; 2007: 261-282. Greinacher A, Warkentin TE. Treatment of heparininduced thrombocytopenia: an overview. In: Warkentin TE, Greinacher A, eds. Heparin-Induced Thrombocytopenia, 4th edn. New York: Informa Healthcare USA, Inc.; 2007: 283-317. Greinacher A, Warkentin TE. Heparin-induced thrombocytopenia. In: Aird WC, ed. Endothelial BioMedicine. Cambridge: Cambridge University Press, 2007 (ISBN 9780521853767): 1344-1351. Warkentin TE. Heparin-induced thrombocytopenia (Chap 25). In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Thrombosis and Hemostasis, 2nd edn. Philadelphia: Saunders Elsevier, 2007: 421-445. WASERMAN, S. Publications Sun J, Wong B, Cundall M, Goncharova S, Conway M, Dalrymple A, Coyle AJ, Waserman S., Jordana M. Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed-induced allergic rhinitis. Clin Exp Allergy 2007; 37:901-908. Sun J, Arias K, Alvarez DA, Fattouh R, Walker T, Goncharova S, Kim B, Waserman S, Reed J, Coyle AJ, Jordana M. Impact of CD40L, B cells and mast cells in peanut-induced anaphylaxis. J. Immunol 2007; 179:6696-703. WAYE, J. Publications Waye JS, Walker L, Kyriakopoulou LG, Potter MA, Eng B. Characterisation of a novel 49.3 kb Ggamma(Agamma delta beta)(0) -thalassaemia deletion in seven families of Asian descent. Br J Haematol 2007; 138:125-126. Waye JS, Chui DHK. Hb Evora [alpha 2-35, Ser-- >Pro], a novel hemoglobin variant associated with an alpha-thalassemia phenotype. Haematologica 2007; 92:92e068. Waye JS, Eng B, Potter MA, Nowaczyk MJM, McFadden D, Langlois S. De Novo mutation of the DHCR7 gene in a fetus with severe Smith-Lemli-Opitz (or RSH) syndrome. Am J Med Genet 2007; 143:1799- 1801. Waye JS, Eng B, Nowaczyk MJM. Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutations analysis. Prenatal Diagn 2007; 27:638-640. Walker L, Eng B, McFarlane A, Waye JS. High oxygen affinity hemoglobin variant in a Canadian family: Hb Bunbury[ ę94(FG1)AspęAsn, GACęAAC]. Hemoglobin 2007; 31:101-103. Eng B, Walker L, Nakamura LM, Hoppe C, Azimi M, Lee H, Waye JS. Three new ę-globin gene promoter mutations identified during newborn screening. Hemoglobin 2007; 31:129-134. WEBERT, K. Publications Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, Lipton JH, Brandwein JM, Heddle NM. A multicenter pilot randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2007; 48(1): 81-91. Whittaker S, Carter N, Arnold E, Shehata N, Webert K, DiStefano L, Heddle N. Understanding the meaning of permanent deferral for blood donors. Transfusion 2007; 48(1):64-72. Webert KE, Arnold DM, Molnar, L, Carruthers J, Almonte T, Decker K, Seroski W, Reed J, Chan A, Pai M, Walker I. Utilization of recombinant activated factor VII in Southern Ontario in 85 patients with and without hemophilia. Haemophilia 2007; 13:518-26. Arnold DM, Webert KE, Carruthers J, Almonte T, Decker K, Seroski W, Reed J, Chan AKC, Pai M and Walker I. Trends in the utilization and wastage of coagulation factor concentrates: the application of a regional tracking programme. Haemophilia 2007; 13:271–278. Arnold DM, Donahoe L, Clarke FJ, Tkaczyk AJ, Heels- Ansdell D, Zytaruk N, Cook RJ, Webert KE, McDonald E, Cook DJ. Bleeding during critical illness: A prospective cohort study using a new measurement tool. Clin Invest Med 2007; 30:E93-E102. Webert KE. Randomization in clinical trials.Transfusion 2007; 47:1753-1754. Webert KE. Treatment allocation in clinical trials. Transfusion 2007; 47(12):2187-8. Book Chapters Webert KE, Kelton JG. Thrombocytopenia in Pregnancy. In: Greer IA, Ginsberg J, Forbes CD, (eds.) Women’s Vascular Health. Oxford University Press, New York, 2007. Webert KE, Kleinman SH, Blajchman MA. Transfusionrelated Acute Lung Injury. In: Hillyer CD, Silberstein LE, Ness, PM, Anderson KC, Roback JD, (eds.) Blood Banking and Transfusion Medicine: Basic Principles and Practice. Second Edition. Elsevier Science, Philadelphia, PA, USA, 2007. Heddle N, Webert KE. Non-infectious complications of transfusion. In: Hillyer CD, Silberstein LE, Ness, PM, Anderson KC, Roback JD, (eds.) Blood Banking and Transfusion Medicine: Basic Principles and Practice. Second Edition. Elsevier Science, Philadelphia, PA, USA, 2007. WEITZ, J. Publications Linkins LA, Weitz JI. Beyond heparin and warfarin: The new generation of anticoagulants. Expert Opinion on Investigational Drugs 2007; 16(3):271-282. McRae SJ, Stafford AR, Fredenburgh JC, Weitz JI. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity. Biochemistry 2007; 46(13):4195-4203. Weitz JI. Emerging anticoagulant drugs. Arteriosclerosis, Thrombosis, and Vascular Biology 2007; 27(4):721. DeCaterina R, Husted S, Wallentin L, Agnelli G, Bachmann F, Baigent C, Jespersen J, Kristensen SD, Montalescot G, Siegbahn A, Verheugt FWA, Weitz JI. Anticoagulants in heart disease: current status and perspectives. European Heart Journal 2007; 28(7):880- 913. Eikelboom J, Weitz JI. A replacement for warfarin: The search continues. (Editorial) Circulation 2007; 116(2):131-133. Weitz JI. Factor Xa or thrombin: Is thrombin a better target? J Thromb Haemost. 2007 Jul; 5 Suppl 1:65-7. Milsom C, Anderson GM, Weitz JI, Rak J. Elevated tissue factor procoagulant activity in CD133-positive cancer cells. Journal of Thrombosis and Haemostasis 2007; 5(12):2550-2552. Milsom C, Yu J, May L, Meehan B, Magnus N, Al- Nedawi K, Luyendyk J, Weitz J, Klement P, Broze G, Mackman N, Rak J. The role of tumor- and host-related tissue factor pools in oncogene-driven tumor progression. Thrombosis Research 2007; 120(Suppl 2):S82- S91. WERSTUCK, G. Publications Punthakee Z, Werstuck GH, Gerstein HC (2007) Diabetes and Cardiovascular Disease: Explaining the Relationship. Reviews in Cardiovascular Medicine 2007; 8:145-153. Shi Y, Gerritsma D, Bowes AJ, Capretta A, Werstuck GH (2007) Induction of GRP78 by valproate is dependent upon histone deactylase inhibition. Bioorg Med Chem Lett 2007; 17:4491-4494. Colgan SM, Tang D, Werstuck GH and Austin RC (2007) Endoplasmic reticulum stress activation of sterol regulatory element binding protein-2. Int J Biochem Cell Biol 2007; 39:1843-1851. WHITEHEAD, L. Book Chapter Long R, Avendano M. Whitehead L. Drug-resistant Tuberculosis. In: Long R, Ellis E, (eds.) Canadian Tuberculosis Standards – 6th Edition. Public Health Agency of Canada, 2007. 146-181.
160 PUBLICATIONS WORSTER, A. Publications Worster A. A Role for Root Cause Analysis in Laboratory Medicine. Labmedicine 2007; 38(12):709- 712. Wathen CN, Jamieson E, Wilson M, Daly M, Worster A, MacMillan HL and the McMaster University Violence Against Women Research Group. Risk indicators to identify intimate partner violence in the emergency department. Open Medicine 2007; 1(2):113-22. Richards D, Meshkat N, Chu J, Eva K, Worster A. Emergency department patient compliance with follow-up for outpatient exercise stress testing: a randomized controlled trial. CJEM 2007 Nov; 9(6):435-40. Daiter J, Teplin D, Varenbut M, Worster A, Raz B. Diagnostic value of self-report of alcohol use in patients enrolled in a methadone maintenance treatment program (MMTP). J Addict Dis 2007; 26(3):87-92. Rowe BH, Diner B, Camargo CA Jr, Worster A, Colacone A, Wyer PC; Knowledge Translation - Consensus Conference Theme Ib Members. Effective synthesized / preappraised evidence formats in emergency medicine and the use of supplemental knowledge translation techniques. Acad Emerg Med 2007 Nov; 14(11):1023-9. Varenbut M, Teplin D, Daiter J, Raz B, Worster A, Frank N, Greenwald I, Konyer A, Emadi-Konjin P, Snider-Adler M. Tampering by office-based methadone maintenance patients with methadone take home privileges: a pilot study.Harm Reduction Journal 2007; 4:15. Daiter J, Teplin D, Varenbut, M, Worster A, Raz B. Diagnostic Value of Self-Report of Alcohol Use in Patients Enrolled in a Methadone Maintenance Treatment Program (MMTP) Journal of Addictive Diseases 2007; 26(3):87-92. Worster A, Fernandes CM, Eva K, Upadhye S. Predictive validity comparison of two five-level triage acuity scales. Eur J Emerg Med 2007 Aug; 14(4) :188- 92. Worster A, Sardo A, Eva K, Fernandes CM, Upadhye S. Triage Tool Inter-rater Reliability: A Comparison of Live Versus Paper Case Scenarios. J Emerg Nurs 2007 Aug; 33(4):319-23. Worster A, Smith C, Silver S, Brown MD. Evidencebased emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism? Ann Emerg Med 2007 Jul; 50(1):78-84. Singh N, Arthur HM, Worster A, Iacobellis G, Sharma AM. Emergency department equipment for obese patients: perceptions of adequacy. J Adv Nurs 2007 Jul; 59(2):140-5. Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, Alonso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schunemann HJ, Permanyer-Miralda G, Pacheco- Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 2007 Apr 14; 334(7597):786. Worster A, Fan J, Ismaila A. Understanding linear and logistic regression analyses. CJEM 2007 Mar; 9(2): 111-3. Upadhye S, Rivers EP, Worster A. Critical care response teams: potential roles for emergency physicians. CJEM 2007 Jan; 9(1):34-7. YOU, J. Publications Ko DT, Krumholz HM, Wang Y, Foody JM, Masoudi FA, Havranek EP, You JJ, Alter DA, Stukel T, Newman AM, Tu JV. Regional differences in process of care and outcomes of older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation 2007; 115:196-203. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, Foody JM, Krumholz HM, Philips CO, You JJ, Kashani A, Tu JV, Ko DT. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007; 30:422-30. You JJ, Austin PC, Alter DA, Ko DT, Tu JV. Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 2007; 153:462-70. You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M. Life expectancy gains and cost-effectiveness of implantable cardioverter defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. Am Heart J 2007; 154:899-907. YUSUF, S. Publications Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG. Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart 2007 Jan; 93(1):59-64. Lewis EF, Lamas GA, O’Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson B, McMurray JJ, Yusuf S, Swedberg K, Pfeffer MA; for the CHARM Investigators. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2007; 9(1):83-91. Merchant AT, Anand SS, Kelemen LE, Vuksan V, Jacobs R, Davis B, Teo K, Yusuf S; SHARE and SHARE-AP Investigators. Carbohydrate intake and HDL in a multiethnic population. Am J Clin Nutr 2007; 85(1):225-30. Joshi P, Islam I, Pais P, Reddy KS, Prabhakaran D, Kazmi K, Pandey MR, Haque S, Mendis S, Yusuf S. Why do South Asians develop myocardial infarction at younger ages compared to other ethnic groups? The INTERHEART South Asia Study. JAMA 2007; 297(3):286-94. Diener HC, Sacco R, Yusuf S. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with Clopidogrel) and telmisartan versus placebo in patients with strokes: The Prevention Regimen for effectively avoiding Second Strokes trial (PRoFESS). Cerebrovasc Dis. 2007; 23(5-6):368-380. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S for the INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America. Circulation 2007; 115(9):1067-74. Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K, on behalf of the ONTARGET/TRANSCEND Investigators. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 2007; 115(11):1371-5. Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E. Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients. Eur Heart J 2007 Jun; 28(11):1277-8. Razak F, Anand SS, Shannon H, Vuksan V, Davis B, Jacobs R, Teo KK, McQueen M, Yusuf S. Defining obesity cut points in a multiethnic population. Circulation 2007 Apr 24; 115(16):2111-8. Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S; for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial investigators. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 2007; 14(2):312-18. Hilbrich L, Truelsen T, Yusuf S. Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development. Int J Stroke 2007; 2:104-8. O’Meara E, Clayton T, McEntegart MB, McMurray JJV, Pina I, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure – results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity Program (CHARM). Circulation 2007; 115:3111-20. Bohm M, Baumhakel M, Probstfield JL, Schmieder R, Yusuf S, Zhao F, Koon T, on Behalf of the ONTARGET/ TRANSCEND-Investigators. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND). Am Heart J. 2007; 154(1):94-101. Peters RJG, Mehta S, Yusuf S. Acute coronary syndromes without ST segment elevation. BMJ 2007; 334:1265-69. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB, for the CHARM investigators. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and Duke Databank. J Am Coll Cardiol 2007; 50(1):40-7. The Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 2007; 357(3):217-227. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LAM, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJV, Solomon SD for the CHARM Investigators. Body mass index and prognosis in patients with chronic heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007; 116:627-36. Connolly SJ, Eikelboom J, O’Donnell M, Pogue J, Yusuf S. Challenges of establishing new antithrombotic therapies in atrial fibrillation. Circulation 2007; 116:449-455. Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP, Vogel V, Walters L, Yusuf S. Monitoring the randomized trials of the Women’s Health Initiative: the experience of the Data and Safety Monitoring Board. Clin Trials 2007; 4(3):218-34. Wang J, Cao H, Ban MR, Kennedy BA, Zhu S, Anand S, Yusuf S, Pollex RL, Hegele RA. Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650). Arterioscler Thromb Vasc Biol 2007 Nov; 27(11):2450-5. Salehian O, Lonn E, Dagenais G, Mathew J, Healey J, Pogue J, Yusuf S. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study. Am Heart J 2007; 154(3):448-53. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA; Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Circulation 2007 Sep 25; 116(13):1482-7. Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P, Piegas LS, Valentin V, Moccetti T, Chrolavicius S, Afzal R, Yusuf S; OASIS 5 Investigators. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med. 2007 Sep 4; 147(5):304-10. Friedewald VE, Bates ER, Granger CB, Yusuf S, Roberts WC. The Editor’s Roundtable: arterial thrombosis and acute coronary syndromes. Am J Cardiol. 2007 Sep 15; 100(6):974-8. Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S; Collaborative Organization of RheothRx Evaluation (CORE) Trial Investigators. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J. 2007 Oct; 154(4):743-50. Yusuf S, Fallen E, Harrington RA, Guyton RA. Clinical Decisions: Management of stable coronary disease. N
Page 1 and 2: 108 Faculty Awards Anand, Sonia Hea
Page 3 and 4: 112 19th Annual Resident Research D
Page 5 and 6: 116 Geographic Full-Time Professor
Page 7 and 8: 120 Fergani, Houssein Gastroenterol
Page 9 and 10: 124 Publications ADACHI, JD Publica
Page 11 and 12: 128 PUBLICATIONS Book Chapters Bley
Page 13 and 14: 132 PUBLICATIONS DOLOVICH, M. Publi
Page 15 and 16: 136 PUBLICATIONS Mills E, Heels Ans
Page 17 and 18: 140 PUBLICATIONS injection in senti
Page 19 and 20: 144 PUBLICATIONS Arnold DM, Dentali
Page 21 and 22: 148 PUBLICATIONS CI. Polymorphism i
Page 23 and 24: 152 PUBLICATIONS Patterns of Candid
Page 25: 156 PUBLICATIONS dehydrogenase kina

Faculty Awards - Faculty of Health Sciences - McMaster University

Create successful ePaper yourself

Delete template?

Save as template?